Skip to main content
. 2023 Sep 3;37(5):2147–2154. doi: 10.21873/invivo.13312

Table V. Fifteen patients administered with ICI.

graphic file with name in_vivo-37-2150-i0001.jpg

ICI, Immune checkpoint inhibitors; TMB, tumor mutation burden; CPS, combined positive score; BOR, best overall response; CGP, cancer genome profiling; SCC, squamous cell carcinoma; SDC, salivary duct carcinoma; ACC, adenoid cystic carcinoma; MM, malignant melanoma.